Accesswire
19 Jun 2026, 23:00 UTC · 2h ago
Onco-Innovations Announces Non-Brokered LIFE Offering
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Accesswire
19 Jun 2026, 23:00 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
Onco-Innovations intends to raise approximately CAD$5 million through a non-brokered private placement of 6,764,069 units at CAD$0.7392 per unit. — Private placements typically cause immediate share price dilution for existing shareholders.
-0.40Net proceeds will be used to advance the ONC010 program clinical development, manufacturing, preclinical testing, and the SynoGraph platform. — Dedicated funding for clinical development and platform advancement is a positive catalyst for long-term pipeline value.
+0.30The offering includes warrants allowing holders to purchase shares at CAD$0.90 for three years, with a company-led acceleration option if the 10-day VWAP reaches CAD$1.30. — Warrants create potential future dilution and can act as a ceiling on price appreciation due to the acceleration clause.
-0.20Continue reading
6 related stories
Top 1 mover · tap to explore
The units will be issued under the Listed Issuer Financing Exemption, meaning they will not be subject to a hold period under Canadian securities laws. — The lack of a hold period allows immediate selling by participants, increasing short-term volatility and selling pressure.
-0.20Which stocks this story touches
The company is raising CAD$5 million in capital to advance its clinical development and technology platforms.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
TheNewswire
4h ago
